Intraperitoneal administration of nesfatin-1 stimulates glucagon-like peptide-1 secretion in fasted mice

Increasing endogenous secretion of glucagon-like peptide (GLP)-1 is considered a promising therapeutic approach for type 2 diabetes because decreased GLP-1 plasma concentrations have been observed in patients with this condition. Nesfatin-1, which is a central and peripheral anorexigenic peptide, ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Tagawa, Noriko, Ogura, Honoka, Miyawaki, Hikaru, Asakawa, Akihiro, Kato, Ikuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685253/
https://www.ncbi.nlm.nih.gov/pubmed/36367173
http://dx.doi.org/10.3892/mmr.2022.12894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685253/
https://www.ncbi.nlm.nih.gov/pubmed/36367173
http://dx.doi.org/10.3892/mmr.2022.12894

Ejemplares similares